Medicare & Medicaid
News articles in this section include actions by federal regulators like the CMS and HHS, as well as information on Medicare and state Medicaid coverage and benefits.
Pharma rarely loses in Washington. For years, the industry has successfully defeated US government efforts to rein in drug pricing, arguing any such moves would prevent companies from developing newer and better medicines. That argument doesn’t seem to be enough anymore.
A full 95% of Medicare beneficiaries are worried about the impact of inflation on healthcare costs. And nearly half of the 2,500 beneficiaries recently surveyed by eHealth say their healthcare costs have already increased due to inflation.
The Centers for Medicare & Medicaid Services (CMS) has pulled back on plans to pause public reporting on certain hospital safety data in the wake of pushback from patient safety advocates. In Monday’s release of the final Inpatient Prospective Payment System (IPPS), CMS detailed numerous changes from a fiscal year 2023 proposal it had laid out in April. ...
The bill, a slimmed-down version of President Joe Biden’s Build Back Better package, also allows Medicare to negotiate select prescription drug prices beginning in 2026 and caps Medicare Part D out-of-pocket costs in 2025.
The CMS is asking for public feedback on how to make the Medicare Advantage program more affordable, sustainable and equitable for enrollees, while driving better health outcomes.
Democrats want to go into their August recess telling their constituents they’re lowering what they pay for medicines — but many of their promised changes won’t be felt for years, and only by a fraction of the nation. Drug-pricing legislation is expected to get a vote in the Senate as soon as this week as ...
The Biden administration finalized a 4.3% bump for inpatient payments for the federal fiscal year 2023, an increase compared to the 3.2% that was originally proposed back in April. The Centers for Medicare and Medicaid Services released on Monday the final Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital Prospective Payment System rule that ...
The feds expect Medicare Part D premiums to decline by nearly 2% next year. The Centers for Medicare & Medicaid Services (CMS) said Friday that it expects the average premium to decrease to $31.50 in 2023, or about 1.8% from the 2022 rate of $32.08. The projected monthly premiums are based on bids to CMS ...
Manchin has told Senate leadership that he will support the extension as part of a narrow spending bill aimed at lowering drug prices, according to a report in Politico. The development comes as the healthcare industry has been imploring Congress to extend the enhanced subsidies that will expire after this year.
A new study found that more Medicare Part D beneficiaries paid the entire generic drug cost at least once in 2020 compared to 2017.